These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Mulligan AM; O'Malley FP; Ennis M; Fantus IG; Goodwin PJ Breast Cancer Res Treat; 2007 Nov; 106(1):39-47. PubMed ID: 17221153 [TBL] [Abstract][Full Text] [Related]
5. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
6. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology. Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157 [TBL] [Abstract][Full Text] [Related]
7. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma. Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704 [TBL] [Abstract][Full Text] [Related]
8. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up. Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma. Yoo C; Song C; Hong JH; Kim CS; Ahn H J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101 [TBL] [Abstract][Full Text] [Related]
10. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival. Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951 [TBL] [Abstract][Full Text] [Related]
12. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [TBL] [Abstract][Full Text] [Related]
13. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882 [TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Rasmuson T; Grankvist K; Jacobsen J; Olsson T; Ljungberg B Acta Oncol; 2004; 43(8):744-8. PubMed ID: 15764220 [TBL] [Abstract][Full Text] [Related]
15. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation]. Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509 [TBL] [Abstract][Full Text] [Related]
16. Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Erkizan O; Kirkali G; Yörükoğlu K; Kirkali Z Urology; 2004 Sep; 64(3):474-8. PubMed ID: 15351573 [TBL] [Abstract][Full Text] [Related]
17. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma. Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826 [TBL] [Abstract][Full Text] [Related]
18. Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Delahunt B; Sika-Paotonu D; Bethwaite PB; William Jordan T; Magi-Galluzzi C; Zhou M; Samaratunga H; Srigley JR Am J Surg Pathol; 2011 Aug; 35(8):1134-9. PubMed ID: 21716085 [TBL] [Abstract][Full Text] [Related]
19. Real indications for adrenalectomy in renal cell carcinoma. Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919 [TBL] [Abstract][Full Text] [Related]
20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V; Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]